• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化医疗护理与冠状动脉血流容量引导的心肌血运重建术对比常规护理治疗慢性冠状动脉疾病:CENTURY试验

Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.

作者信息

Gould K Lance, Johnson Nils P, Roby Amanda E, Kirkeeide Richard, Haynie Mary, Nguyen Tung, Bui Linh, Patel Monica B, Kitkungvan Danai, Mendoza Patricia, Lai Dejian, Li Ruosha, Sdringola Stefano, McPherson David, Narula Jagat

机构信息

Weatherhead PET Center for Preventing and Reversing Atherosclerosis, Division of Cardiology, Department of Medicine, University of Texas McGovern Medical School, 6431 Fannin St., Room MSB 4.256, and Memorial Hermann Hospital, Houston, TX 77030, USA.

Department of Biostatistics and Data Science, University of Texas School of Public Health, Houston, TX, USA.

出版信息

Eur Heart J. 2025 Sep 2;46(33):3273-3286. doi: 10.1093/eurheartj/ehaf356.

DOI:10.1093/eurheartj/ehaf356
PMID:40439159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12401582/
Abstract

BACKGROUND AND AIMS

The randomized CENTURY trial tested the hypothesis that a comprehensive strategy integrating intense lifestyle modification and aggressive medical management to goals with revascularization reserved for severely reduced coronary flow capacity (CFC) by positron emission tomography (PET) would reduce risk factors, subsequent revascularization, death and myocardial infarction (MI) compared with standard of care in chronic stable coronary artery disease (CAD).

METHODS

Participants were randomly assigned to standard or comprehensive care groups. Rest-stress PET quantified CFC for physiological CAD severity at baseline, 2, 5, and up to 11 years. The comprehensive care group reviewed PET results with frequent clinic visits and open 24/7 phone/email support. Standard care lacked supportive contact with blinded PET results that were unblinded only for severely reduced CFC with high mortality risk for potential revascularization.

RESULTS

Between 2009-2017, 515 patients were assigned to comprehensive care and 513 to standard care and followed for 5 or more years. Comprehensive vs standard care decreased risk factors and summed 5-year risk score (Δ-1.1 vs + 0.33; 95% confidence interval -1.84 to -0.97; P < .0001), decreased cumulative 11-year all-cause death (4.7% vs 8.2%; P = .023), death or MI (7.0% vs 11.1%; P = .024) late revascularization (9.5% vs 14.8%; P = .021) and major adverse cardiac events (20.5% vs 29.9%; P = .0006). Only 56 of 1028 (5.4%) CENTURY patients with chronic CAD had revascularization within 90 days predominantly guided by CFC severity.

CONCLUSIONS

The randomized CENTURY trial demonstrates that comprehensive integrated lifestyle modification and medical management towards goals with revascularization reserved for severely reduced CFC, significantly reduced risk factor scores, death, death or MI, and revascularization.

CLINICALTRIALS.GOV: NCT00756379.

摘要

背景与目的

随机对照的CENTURY试验检验了以下假设:与慢性稳定型冠状动脉疾病(CAD)的标准治疗相比,一种综合策略,即整合强化生活方式改变和积极的药物治疗以实现目标,并将血管重建术保留用于通过正电子发射断层扫描(PET)显示冠状动脉血流容量(CFC)严重降低的情况,将降低风险因素、后续血管重建术、死亡和心肌梗死(MI)的发生率。

方法

参与者被随机分配到标准治疗组或综合治疗组。静息-负荷PET在基线、2年、5年以及长达11年时对生理性CAD严重程度进行CFC定量。综合治疗组通过频繁门诊就诊以及24/7开放的电话/电子邮件支持来查看PET结果。标准治疗缺乏对PET结果的支持性沟通,PET结果仅在CFC严重降低且具有潜在血管重建术高死亡风险时才解除盲法。

结果

在2009年至2017年期间,515例患者被分配到综合治疗组,513例患者被分配到标准治疗组,并随访5年或更长时间。与标准治疗相比,综合治疗降低了风险因素和5年风险总分(差值为-1.1 vs +0.33;95%置信区间为-1.84至-0.97;P <.0001),降低了11年累积全因死亡率(4.7% vs 8.2%;P =.023)、死亡或MI发生率(7.0% vs 11.1%;P =.024)、晚期血管重建术发生率(9.5% vs 14.8%;P =.021)以及主要不良心脏事件发生率(20.5% vs 29.9%;P =.0006)。在1028例CENTURY慢性CAD患者中,只有56例(5.4%)在90天内进行了血管重建术,主要由CFC严重程度指导。

结论

随机对照的CENTURY试验表明,综合强化生活方式改变和药物治疗以实现目标,并将血管重建术保留用于CFC严重降低的情况,可显著降低风险因素评分、死亡、死亡或MI以及血管重建术的发生率。

临床试验注册

NCT00756379。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/e8b75d900e6d/ehaf356f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/357bab78c36f/ehaf356_sga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/98d69c78db77/ehaf356f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/52f9621f7b88/ehaf356f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/8d91bf3daba1/ehaf356f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/be19d4f0a27b/ehaf356f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/33b149823f07/ehaf356f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/37c0565e4044/ehaf356f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/13497231a25d/ehaf356f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/e8b75d900e6d/ehaf356f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/357bab78c36f/ehaf356_sga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/98d69c78db77/ehaf356f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/52f9621f7b88/ehaf356f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/8d91bf3daba1/ehaf356f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/be19d4f0a27b/ehaf356f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/33b149823f07/ehaf356f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/37c0565e4044/ehaf356f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/13497231a25d/ehaf356f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4f2/12401582/e8b75d900e6d/ehaf356f8.jpg

相似文献

1
Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.优化医疗护理与冠状动脉血流容量引导的心肌血运重建术对比常规护理治疗慢性冠状动脉疾病:CENTURY试验
Eur Heart J. 2025 Sep 2;46(33):3273-3286. doi: 10.1093/eurheartj/ehaf356.
2
Ischemia targeted coronary revascularization improves 5-year survival following carotid endarterectomy.缺血靶向冠状动脉血运重建可改善颈动脉内膜切除术后的5年生存率。
J Vasc Surg. 2025 Aug;82(2):517-525. doi: 10.1016/j.jvs.2025.03.197. Epub 2025 Mar 28.
3
Psychological interventions for coronary heart disease.冠心病的心理干预措施。
Cochrane Database Syst Rev. 2017 Apr 28;4(4):CD002902. doi: 10.1002/14651858.CD002902.pub4.
4
Design and rationale of the randomized trial of comprehensive lifestyle modification, optimal pharmacological treatment and utilizing PET imaging for quantifying and managing stable coronary artery disease (the CENTURY study).综合生活方式改变、最佳药物治疗和利用正电子发射断层扫描(PET)成像来量化和管理稳定型冠状动脉疾病的随机临床试验的设计和原理(CENTURY 研究)。
Am Heart J. 2021 Jul;237:135-146. doi: 10.1016/j.ahj.2021.03.012. Epub 2021 Mar 21.
5
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.FFR 引导的心肌梗死患者完全血运重建或罪犯病变血运重建。
N Engl J Med. 2024 Apr 25;390(16):1481-1492. doi: 10.1056/NEJMoa2314149. Epub 2024 Apr 8.
6
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
7
Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease.区域、动脉特异性定量心肌灌注 PET 阈值与稳定型冠状动脉疾病血运重建后心肌梗死和死亡减少相关。
J Nucl Med. 2019 Mar;60(3):410-417. doi: 10.2967/jnumed.118.211953. Epub 2018 Aug 16.
8
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.多血管 PCI 治疗心肌梗死的完全血运重建时机。
N Engl J Med. 2023 Oct 12;389(15):1368-1379. doi: 10.1056/NEJMoa2307823. Epub 2023 Aug 27.
9
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
10
Comparing FFR-Guided Complete Revascularization and Conservative Management for Non-Culprit Lesions in STEMI Patients With Multivessel Disease: A Systematic Review and Meta-Analysis.比较FFR指导的完全血运重建与保守治疗对多支血管病变STEMI患者非罪犯病变的疗效:一项系统评价和荟萃分析
Catheter Cardiovasc Interv. 2025 Feb;105(3):633-642. doi: 10.1002/ccd.31379. Epub 2024 Dec 24.

本文引用的文献

1
Reproducibility of quantitative myocardial perfusion and coronary flow capacity by positron emission tomography: 3D digital silicon photomultiplier solid state vs. legacy 2D analogue systems for clinical practice and trials.正电子发射断层扫描定量心肌灌注和冠状动脉血流容量的可重复性:用于临床实践和试验的3D数字硅光电倍增管固态系统与传统2D模拟系统的比较
Eur Heart J Imaging Methods Pract. 2024 Dec 9;2(3):qyae115. doi: 10.1093/ehjimp/qyae115. eCollection 2024 Jul.
2
Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial.急性心肌梗死患者低密度脂蛋白胆固醇降低治疗的病变水平效应:PACMAN-AMI试验的事后分析
JAMA Cardiol. 2024 Dec 1;9(12):1082-1092. doi: 10.1001/jamacardio.2024.3200.
3
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
4
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions.优化稳定型心绞痛管理:以患者为中心的血运重建、药物治疗和生活方式干预综合治疗策略。
J Am Coll Cardiol. 2024 Aug 20;84(8):744-760. doi: 10.1016/j.jacc.2024.06.015.
5
Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications.冠状动脉血流储备能力与血运重建后生存预测:生理基础与临床意义。
Eur Heart J. 2024 Jan 14;45(3):181-194. doi: 10.1093/eurheartj/ehad579.
6
2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.2023年美国心脏协会/美国心脏病学会冠状动脉血运重建临床绩效与质量指标:美国心脏病学会/美国心脏协会绩效指标联合委员会报告
J Am Coll Cardiol. 2023 Sep 12;82(11):1131-1174. doi: 10.1016/j.jacc.2023.03.409. Epub 2023 Jul 27.
7
Microvascular Dysfunction or Diffuse Epicardial CAD With Normal Stress Vasodilation.微血管功能障碍或应激性血管舒张正常的弥漫性心外膜冠状动脉疾病。
JACC Cardiovasc Imaging. 2023 Apr;16(4):549-552. doi: 10.1016/j.jcmg.2022.10.029. Epub 2023 Mar 8.
8
Subendocardial and Transmural Myocardial Ischemia: Clinical Characteristics, Prevalence, and Outcomes With and Without Revascularization.心内膜下和透壁性心肌缺血:有或无血运重建情况下的临床特征、患病率及预后
JACC Cardiovasc Imaging. 2023 Jan;16(1):78-94. doi: 10.1016/j.jcmg.2022.05.016. Epub 2022 Sep 14.
9
Autoregulation of Coronary Blood Supply in Response to Demand: JACC Review Topic of the Week.冠状动脉血流的自动调节以响应需求:JACC 每周综述专题。
J Am Coll Cardiol. 2021 May 11;77(18):2335-2345. doi: 10.1016/j.jacc.2021.03.293.
10
Design and rationale of the randomized trial of comprehensive lifestyle modification, optimal pharmacological treatment and utilizing PET imaging for quantifying and managing stable coronary artery disease (the CENTURY study).综合生活方式改变、最佳药物治疗和利用正电子发射断层扫描(PET)成像来量化和管理稳定型冠状动脉疾病的随机临床试验的设计和原理(CENTURY 研究)。
Am Heart J. 2021 Jul;237:135-146. doi: 10.1016/j.ahj.2021.03.012. Epub 2021 Mar 21.